User:Zmondlak/sandbox

Welcome to the first draft of the Catatonia Scales document! Sources:

Al Sayegh, A., & Reid, D. (2010). Prevalence of catatonic signs in acute psychiatric patients in Scotland. The Psychiatrist, 34(11), 479-484.

Bush, G., Fink, M., Petrides, G., Dowling, F., & Francis, A. (1996). Catatonia. I. Rating scale and standardized examination. Acta Psychiatrica Scandinavica, 93(2), 129-136.

Bräunig, P., Krüger, S., Shugar, G., Höffler, J., & Börner, I. (2000). The catatonia rating scale I—Development, reliability, and use. Comprehensive Psychiatry, 41(2), 147-158.

Carroll, B. T., Kirkhart, R., Ahuja, N., Soovere, I., Lauterbach, E. C., Dhossche, D., & Talbert, R. (2008). Katatonia: A new conceptual understanding of catatonia and a new rating scale. Psychiatry (Edgmont), 5(12), 42.

McKenna, P. J., Lund, C. E., Mortimer, A. M., & Biggins, C. A. (1991). Motor, Volitional and Behavioural Disorders in Schizophrenia: 2: The ‘Conflict of Paradigms' Hypothesis. The British Journal of Psychiatry, 158(3), 328-336.

Northoff, G., Koch, A., Wenke, J., Eckert, J., Böker, H., Pflug, B., & Bogerts, B. (1999). Catatonia as a psychomotor syndrome: A rating scale and extrapyramidal motor symptoms. Movement disorders: Official Journal of the Movement Disorder Society, 14(3), 404-416.

Starkstein, S. E., Petracca, G., Teson, A., Chemerinski, E., Merello, M., Migliorelli, R., & Leiguarda, R. (1996). Catatonia in depression: Prevalence, clinical correlates, and validation of a scale. Journal of Neurology, Neurosurgery & Psychiatry, 60(3), 326-332.

Welcome to the first draft of the Psychosis scales document! Haddock, G., McCarron, J., Tarrier, N., & Faragher, E. B. (1999). Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychological Medicine, 29(4), 879-889.

Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261-276.

Lukoff, D., Liberman, R. P., & Nuechterlein, K. H. (1986). Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophrenia Bulletin, 12(4), 578-603.

Miller, T. J., McGlashan, T. H., Woods, S. W., Stein, K., Driesen, N., Corcoran, C. M., ... & Davidson, L. (1999). Symptom assessment in schizophrenic prodromal states. Psychiatric Quarterly, 70, 273-287.

Nelson, B. (2014). The CAARMS: Assessing young people at ultra high risk of psychosis. Orygen Youth Health Research Centre.

Yung, A. R., Yung, A. R., Pan Yuen, H., Mcgorry, P. D., Phillips, L. J., Kelly, D., ... & Buckby, J. (2005). Mapping the onset of psychosis: The comprehensive assessment of at-risk mental states. Australian & New Zealand Journal of Psychiatry, 39(11-12), 964-971. Summary of Fried et al. (2017)'s journal article on “The 52 symptoms of major depression: Lack of content overlap among seven common depression scales”

Certainly! In the study titled “The 52 symptoms of major depression: Lack of content overlap among seven common depression scales,” researchers investigated the differences in item content and generalizability among seven commonly used depression scales. Here are the key findings:


 * The seven depression scales collectively encompass 52 distinct symptoms.
 * The mean overlap among all scales is low (0.36).
 * The overlap of each scale with all others ranges from 0.27 to 0.40.
 * Individual scales exhibit overlap ranging from 0.26 to 0.61.
 * Symptoms appear across an average of three scales.
 * 40% of the symptoms are unique to a single scale, while 12% appear across all instruments.

This heterogeneity in symptom representation across scales highlights the need for caution when interpreting research results based on specific depression assessment tools. It underscores the importance of considering the replicability and generalizability of findings in depression research. If you’d like more details or have any other questions, feel free to ask! 😊

Method: The study performed a content analysis to assess symptom overlap among the seven scales using the Jaccard index (ranging from 0 for no overlap to 1 for full overlap). It also computed rates of idiosyncratic symptoms and specific versus compound symptoms for each scale